发明名称 NEUROTROPHIC FACTOR MANF AND USES THEREOF
摘要 The present invention generally relates to the field of treatment of neuronal disorders and more particularly to neurotrophic factor MANF and uses thereof. The present invention provides a pharmaceutical compound comprising MANF nucleic acid molecule, MANF protein or a functional fragment thereof for the treatment of a peripherial neuropathy including Alzheimer's disease, Parkinson's disease, epilepsy, drug addiction and ischemic brain injury.
申请公布号 US2015020222(A1) 申请公布日期 2015.01.15
申请号 US201414480975 申请日期 2014.09.09
申请人 HERANTIS PHARMA, PLC. 发明人 SAARMA Mart;LINDHOLM Päivi;VOUTILAINEN Merja;PERÄNEN Johan;TUOMINEN Raimo;AIRAVAARA Mikko;LEPPÄNEN Veli-Matti;LINDAHL Maria;ANDRESSOO Jaan-Olle
分类号 A61K38/18;A01K67/027;C07K14/475 主分类号 A61K38/18
代理机构 代理人
主权项 1. A method of treatment of an individual having Alzheimer's disease, Parkinson's disease, epilepsy, drug addiction or ischemic brain injury, said method comprising: administering to the individual a therapeutically effective amount of MANF polypeptide comprising the amino acid sequence of SEQ ID NO:2 or a functional fragment thereof, wherein said polypeptide is a mesencephalic astrocyte-derived neurotrophic factor (MANF) polypeptide, and wherein said functional fragment is a MANF polypeptide having SEQ ID NO:4 and is capable of preventing the 6-hydroxydopamine (6-OHDA)-induced degeneration of dopaminergic neurons.
地址 Helsinki FI